321 related articles for article (PubMed ID: 24644101)
1. Tear cathepsin S as a candidate biomarker for Sjögren's syndrome.
Hamm-Alvarez SF; Janga SR; Edman MC; Madrigal S; Shah M; Frousiakis SE; Renduchintala K; Zhu J; Bricel S; Silka K; Bach D; Heur M; Christianakis S; Arkfeld DG; Irvine J; Mack WJ; Stohl W
Arthritis Rheumatol; 2014 Jul; 66(7):1872-81. PubMed ID: 24644101
[TBL] [Abstract][Full Text] [Related]
2. Increased Cathepsin S activity associated with decreased protease inhibitory capacity contributes to altered tear proteins in Sjögren's Syndrome patients.
Edman MC; Janga SR; Meng Z; Bechtold M; Chen AF; Kim C; Naman L; Sarma A; Teekappanavar N; Kim AY; Madrigal S; Singh S; Ortiz E; Christianakis S; Arkfeld DG; Mack WJ; Heur M; Stohl W; Hamm-Alvarez SF
Sci Rep; 2018 Jul; 8(1):11044. PubMed ID: 30038391
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal analysis of tear cathepsin S activity levels in male non-obese diabetic mice suggests its potential as an early stage biomarker of Sjögren's Syndrome.
Janga SR; Shah M; Ju Y; Meng Z; Edman MC; Hamm-Alvarez SF
Biomarkers; 2019 Feb; 24(1):91-102. PubMed ID: 30126300
[TBL] [Abstract][Full Text] [Related]
4. Degradation of proteoglycan 4/lubricin by cathepsin S: Potential mechanism for diminished ocular surface lubrication in Sjögren's syndrome.
Regmi SC; Samsom ML; Heynen ML; Jay GD; Sullivan BD; Srinivasan S; Caffery B; Jones L; Schmidt TA
Exp Eye Res; 2017 Aug; 161():1-9. PubMed ID: 28549901
[TBL] [Abstract][Full Text] [Related]
5. Tear miRNAs Identified in a Murine Model of Sjögren's Syndrome as Potential Diagnostic Biomarkers and Indicators of Disease Mechanism.
Kakan SS; Edman MC; Yao A; Okamoto CT; Nguyen A; Hjelm BE; Hamm-Alvarez SF
Front Immunol; 2022; 13():833254. PubMed ID: 35309364
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of Cathepsin S Reduces Lacrimal Gland Inflammation and Increases Tear Flow in a Mouse Model of Sjögren's Syndrome.
Klinngam W; Janga SR; Lee C; Ju Y; Yarber F; Shah M; Guo H; Wang D; MacKay JA; Edman MC; Hamm-Alvarez SF
Sci Rep; 2019 Jul; 9(1):9559. PubMed ID: 31267034
[TBL] [Abstract][Full Text] [Related]
7. Cathepsin S activation contributes to elevated CX3CL1 (fractalkine) levels in tears of a Sjögren's syndrome murine model.
Fu R; Guo H; Janga S; Choi M; Klinngam W; Edman MC; Hamm-Alvarez SF
Sci Rep; 2020 Jan; 10(1):1455. PubMed ID: 31996771
[TBL] [Abstract][Full Text] [Related]
8. Differential Diagnosis of Sjögren Versus Non-Sjögren Dry Eye Through Tear Film Biomarkers.
Akpek EK; Wu HY; Karakus S; Zhang Q; Masli S
Cornea; 2020 Aug; 39(8):991-997. PubMed ID: 32195754
[TBL] [Abstract][Full Text] [Related]
9. Imbalanced Rab3D versus Rab27 increases cathepsin S secretion from lacrimal acini in a mouse model of Sjögren's Syndrome.
Meng Z; Edman MC; Hsueh PY; Chen CY; Klinngam W; Tolmachova T; Okamoto CT; Hamm-Alvarez SF
Am J Physiol Cell Physiol; 2016 Jun; 310(11):C942-54. PubMed ID: 27076615
[TBL] [Abstract][Full Text] [Related]
10. A cohort study of T helper 17 cell-related cytokine levels in tear samples of systemic lupus erythematosus and Sjögren's syndrome patients with dry eye disease.
Peng X; Lu Y; Wei J; Lin T; Lu Q; Liu Q; Ting WJ
Clin Exp Rheumatol; 2021; 39 Suppl 133(6):159-165. PubMed ID: 34596026
[TBL] [Abstract][Full Text] [Related]
11. Phenylephrine increases tear cathepsin S secretion in healthy murine lacrimal gland acinar cells through an alternative secretory pathway.
Fu R; Janga S; Edman MC; Hamm-Alvarez SF
Exp Eye Res; 2021 Oct; 211():108760. PubMed ID: 34487726
[TBL] [Abstract][Full Text] [Related]
12. Rapamycin Eye Drops Suppress Lacrimal Gland Inflammation In a Murine Model of Sjögren's Syndrome.
Shah M; Edman MC; Reddy Janga S; Yarber F; Meng Z; Klinngam W; Bushman J; Ma T; Liu S; Louie S; Mehta A; Ding C; MacKay JA; Hamm-Alvarez SF
Invest Ophthalmol Vis Sci; 2017 Jan; 58(1):372-385. PubMed ID: 28122086
[TBL] [Abstract][Full Text] [Related]
13. Manifestation of meibomian gland dysfunction in patients with Sjögren's syndrome, non-Sjögren's dry eye, and non-dry eye controls.
Kang YS; Lee HS; Li Y; Choi W; Yoon KC
Int Ophthalmol; 2018 Jun; 38(3):1161-1167. PubMed ID: 28567496
[TBL] [Abstract][Full Text] [Related]
14. Proteomic and histopathological characterisation of sicca subjects and primary Sjögren's syndrome patients reveals promising tear, saliva and extracellular vesicle disease biomarkers.
Aqrawi LA; Galtung HK; Guerreiro EM; Øvstebø R; Thiede B; Utheim TP; Chen X; Utheim ØA; Palm Ø; Skarstein K; Jensen JL
Arthritis Res Ther; 2019 Jul; 21(1):181. PubMed ID: 31366407
[TBL] [Abstract][Full Text] [Related]
15. Oral and ocular manifestations in Sjögren's syndrome.
Kalk WW; Mansour K; Vissink A; Spijkervet FK; Bootsma H; Kallenberg CG; Roodenburg JL; Nieuw Amerongen AV
J Rheumatol; 2002 May; 29(5):924-30. PubMed ID: 12022351
[TBL] [Abstract][Full Text] [Related]
16. Rab27a Contributes to Cathepsin S Secretion in Lacrimal Gland Acinar Cells.
Fu R; Edman MC; Hamm-Alvarez SF
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562815
[TBL] [Abstract][Full Text] [Related]
17. The European Community Study Group on diagnostic criteria for Sjögren's syndrome. Sensitivity and specificity of tests for ocular and oral involvement in Sjögren's syndrome.
Vitali C; Moutsopoulos HM; Bombardieri S
Ann Rheum Dis; 1994 Oct; 53(10):637-47. PubMed ID: 7979575
[TBL] [Abstract][Full Text] [Related]
18. The Potential Role for Early Biomarker Testing as Part of a Modern, Multidisciplinary Approach to Sjögren's Syndrome Diagnosis.
Beckman KA; Luchs J; Milner MS; Ambrus JL
Adv Ther; 2017 Apr; 34(4):799-812. PubMed ID: 28283891
[TBL] [Abstract][Full Text] [Related]
19. Analysis of novel Sjogren's syndrome autoantibodies in patients with dry eyes.
Everett S; Vishwanath S; Cavero V; Shen L; Suresh L; Malyavantham K; Lincoff-Cohen N; Ambrus JL
BMC Ophthalmol; 2017 Mar; 17(1):20. PubMed ID: 28270126
[TBL] [Abstract][Full Text] [Related]
20. Tear fluid measurement of anti-SS-A and anti-SS-B antibody in anti-SS-A and anti-SS-B seronegative Sjögren's syndrome patients.
Zandbelt M; te Boome L; Klasen I; van de Putte L; van den Hoogen F
Clin Exp Rheumatol; 2009; 27(3):536. PubMed ID: 19604453
[No Abstract] [Full Text] [Related]
[Next] [New Search]
